Intraperitoneal instillation of Ropivacaine at gynaecological laparoscopy: a randomised control trial

Phase 2

• Conditions: post operative pain; hysterectomy; endometriosis; Surgery - Other surgery; Anaesthesiology - Pain management

• Registration Number: ACTRN12620001055998
• Lead Sponsor: Vanessa Lusink

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-16
• Last Update Posted: 26 October 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 126

Inclusion Criteria

Age over 18.
Surgery for - laparoscopic hysterectomy or resection of endometriosis of sufficient volume to result in 3 x compartment resection.

Exclusion Criteria

Severe liver dysfunction
Severe kidney dysfunction
Allergy to Ropivacaine
Pre-existing pain syndrome with daily opioid use of > 3 months duration.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS pain score.[at 1, 4, 8 and 24 hours post operatively. ]

Secondary Outcome Measures

Name	Time	Method
Consumption of opioid analgesia which will be assessed via the return of patient information forms and assessment of data within the medical record. [1, 4, 8, 24 and 72 hours post-operatively. ];Time to hospital discharge which will be determined from the time of surgery, to the time that the patient is discharged, as will be assessed from data linked to the medical record. [The timepoint will be from the time of completion of surgery to the time in hours to discharge from that same admission from hospital. ]